G6PD Test at Ayzal Lab

G6PD (Glucose 6 Phosphate Dehydrogenase) at Ayzal Lab

The Glucose-6-Phosphate Dehydrogenase (G6PD) test is a specialized diagnostic laboratory investigation that measures the levels and activity of the G6PD enzyme in a patient’s red blood cells. G6PD is a vital cytosolic enzyme that plays a critical role in the pentose phosphate pathway, a metabolic pathway essential for maintaining cellular homeostasis. This enzyme is particularly crucial for red blood cells (erythrocytes), as it helps protect them from premature destruction caused by oxidative stress. Red blood cells are constantly exposed to oxygen and various oxidizing agents from medications, infections, and certain foods. Without adequate G6PD enzyme activity, these oxidizing agents can damage the cellular membrane and hemoglobin, leading to acute hemolysis (the premature destruction of red blood cells) and subsequent hemolytic anemia.

At Ayzal Lab, located in Lahore, Pakistan, the G6PD test is performed using advanced automated chemistry and hematology analyzers to ensure the highest level of clinical precision. This laboratory investigation is categorized under clinical pathology and hematology. It does not involve any imaging or contrast media, as it is a blood-based diagnostic test. The primary specimen evaluated is a whole blood sample, typically collected via venipuncture. The clinical importance of this test lies in its ability to identify individuals with G6PD deficiency, an inherited, X-linked recessive genetic disorder. By detecting this deficiency early, healthcare providers can guide patients on avoiding specific triggers, thereby preventing life-threatening hemolytic crises and managing chronic non-spherocytic hemolytic anemia effectively.

Clinical Procedure: What to Expect

Patient Preparation

Proper patient preparation is essential to ensure accurate test results and avoid false readings. Patients undergoing the G6PD test at Ayzal Lab should adhere to the following guidelines:

• Fasting Requirements: Generally, fasting is not strictly required for a standalone G6PD test. However, if other concurrent blood tests are scheduled, a fasting period of 8 to 12 hours may be necessary.
• Medication Review: Inform your prescribing physician and the laboratory staff about all medications, vitamins, and herbal supplements you are currently taking. Certain oxidizing drugs, such as antimalarials (e.g., primaquine), sulfonamides, and certain antibiotics, can trigger hemolytic episodes and affect active enzyme levels.
• Timing of the Test: The G6PD test should ideally not be performed immediately after an acute hemolytic episode or a blood transfusion. During an acute hemolytic event, older red blood cells with lower enzyme levels are destroyed first, leaving behind younger cells (reticulocytes) which naturally have higher G6PD activity. This can lead to a false-normal result. It is typically recommended to wait several weeks after a hemolytic crisis or transfusion before testing.
• Hydration: Ensure you are well-hydrated before the blood draw, as this makes the veins more accessible and facilitates a smoother collection process.

During the Procedure

The G6PD test is a straightforward outpatient blood draw performed by experienced phlebotomists at Ayzal Lab. The procedure involves the following steps:

• Patient Positioning: The patient is comfortably seated in a blood collection chair, and the arm is extended on a supportive armrest.
• Site Selection and Cleansing: The phlebotomist identifies a suitable vein, typically the median cubital vein in the antecubital fossa (inner elbow). The skin over the selected site is thoroughly sanitized with an antiseptic swab (usually 70% isopropyl alcohol) and allowed to air dry to prevent specimen contamination.
• Tourniquet Application: A sterile elastic tourniquet is applied a few inches above the puncture site to restrict venous blood flow, making the vein more prominent and easier to access.
• Venipuncture: A sterile, single-use needle attached to a vacuum collection tube (typically containing EDTA as an anticoagulant) is gently inserted into the vein. The patient may feel a brief, minor pinch or prick.
• Sample Collection: The blood flows naturally into the collection tube. Once the required volume is obtained, the tourniquet is released, and the needle is carefully withdrawn.
• Post-Puncture Care: Immediate pressure is applied to the puncture site with a sterile cotton ball or gauze pad to promote hemostasis and prevent hematoma formation. A small adhesive bandage is then applied.
• Duration and Safety: The entire sample collection process takes less than five minutes. It is a highly safe procedure with minimal risks, which may include mild bruising, localized soreness, or very rarely, a minor infection at the puncture site.

When is a G6PD Test Performed?

Diagnosis of Neonatal Jaundice

Physicians frequently request a G6PD test for newborns presenting with severe, prolonged, or unexplained neonatal jaundice (hyperbilirubinemia). In infants with G6PD deficiency, the rapid breakdown of red blood cells leads to an excess accumulation of bilirubin in the bloodstream. If left untreated, extremely high levels of bilirubin can cross the blood-brain barrier, causing a severe form of brain damage known as kernicterus. Early detection through G6PD screening allows pediatricians to initiate prompt phototherapy or exchange transfusions, safeguarding the infant’s neurological development.

Investigation of Acute Hemolytic Anemia

When a patient exhibits classic symptoms of acute hemolytic anemia, such as sudden fatigue, pale skin, dark tea-colored urine, rapid heart rate, and shortness of breath, a G6PD test is clinically indicated. These symptoms often manifest rapidly after exposure to oxidative triggers, such as fava beans (favism), bacterial or viral infections, or specific oxidizing medications. The test helps clinicians determine if an underlying G6PD deficiency is the primary cause of the accelerated erythrocyte destruction, allowing for targeted supportive care and trigger avoidance.

Pre-Medication Screening

Before prescribing certain high-risk medications known to induce oxidative stress, healthcare providers routinely order a G6PD test as a preventive measure. Medications such as primaquine (used for malaria eradication), dapsone (used for leprosy and skin conditions), rasburicase, and certain sulfone-based drugs can precipitate severe hemolytic crises in G6PD-deficient individuals. Screening patients beforehand ensures that alternative, safer therapeutic options are selected, preventing drug-induced hematological emergencies.

Evaluation of Unexplained Hemolysis

In cases where patients present with chronic, low-grade, or recurrent episodes of unexplained hemolysis, a G6PD test is an integral part of the diagnostic workup. Some variants of G6PD deficiency cause chronic non-spherocytic hemolytic anemia, where red blood cells are continuously destroyed even in the absence of obvious external triggers. Identifying the enzyme deficiency helps hematologists establish an accurate diagnosis, rule out other hemolytic disorders (such as autoimmune hemolytic anemia or hereditary spherocytosis), and formulate long-term management strategies.

Family History and Genetic Counseling

Because G6PD deficiency is an inherited X-linked recessive disorder, it is passed down from parents to offspring. If there is a known family history of G6PD deficiency, hemolytic anemia, or unexplained severe neonatal jaundice, physicians may recommend testing for family members, especially male infants and maternal relatives. This proactive screening assists in genetic counseling, helping families understand the inheritance patterns, identify carriers, and implement necessary lifestyle modifications to prevent accidental exposure to oxidative agents.

What Does a G6PD Test Detect?

The G6PD test is designed to measure the quantitative activity of the glucose-6-phosphate dehydrogenase enzyme within red blood cells, as well as screen for qualitative deficiencies. Specifically, the test detects and evaluates:

• Quantitative G6PD Enzyme Activity: Measures the exact level of enzyme activity, typically expressed in units per gram of hemoglobin (U/g Hb), helping to classify the severity of the deficiency.
• Severe G6PD Deficiency (Class I & II): Detects extremely low or near-absent enzyme activity, which is associated with chronic non-spherocytic hemolytic anemia or acute hemolytic episodes triggered by minimal oxidative stress.
• Moderate G6PD Deficiency (Class III): Identifies moderate depletion of enzyme activity (typically 10% to 60% of normal), where hemolysis is usually self-limiting and only occurs upon exposure to significant oxidative triggers like infections or specific drugs.
• Normal G6PD Enzyme Levels (Class IV): Confirms adequate enzyme activity, indicating that the patient’s red blood cells possess normal antioxidant defenses and that any hemolytic symptoms are likely due to other etiologies.
• Carrier Status in Females: Helps identify heterozygous females who carry one mutated gene. While carriers often have normal or near-normal overall enzyme levels due to random X-chromosome inactivation, some may have sufficiently reduced levels to experience mild symptoms under severe oxidative stress.
• Drug-Induced Hemolysis Risk: Assesses the patient’s susceptibility to developing acute hemolytic anemia when exposed to oxidizing therapeutic agents.
• Favism Susceptibility: Determines whether a patient is at risk of severe hemolytic reactions after consuming fava beans or inhaling fava plant pollen.
• Infection-Triggered Hemolysis Risk: Evaluates the likelihood of a patient experiencing a drop in red blood cell count during active bacterial or viral infections, which naturally generate inflammatory oxidants.
• Erythrocyte Integrity: Indirectly assesses the metabolic health and survival capacity of the patient’s red blood cell population under oxidative challenges.

Turnaround Time and Report Access at Ayzal Lab

At Ayzal Lab, we understand that timely diagnostic results are crucial for effective clinical decision-making and patient peace of mind. The G6PD test is processed using state-of-the-art automated systems that ensure rapid and highly accurate analysis. Typically, the G6PD test report is completed and verified by our consultant pathologists within 24 to 48 hours of sample collection. Once the results are finalized, patients receive an automated SMS notification. Reports can be accessed easily online through the official Ayzal Lab patient portal, downloaded as a secure PDF, or collected in person from our main diagnostic center in Lahore.

G6PD Findings Overview

The following table outlines the general clinical parameters evaluated during a G6PD test, along with typical normal ranges and potential abnormal findings:

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
G6PD Enzyme Activity (Quantitative)	Normal activity (typically 7.0 – 20.5 U/g Hb, subject to lab-specific reference ranges)	Decreased activity (below 60% of normal indicates deficiency; below 10% indicates severe deficiency)
Red Blood Cell (RBC) Count	Normal range (Male: 4.5–5.9 x10^12/L; Female: 4.1–5.1 x10^12/L)	Decreased RBC count (indicative of active hemolysis or anemia)
Hemoglobin (Hb) Level	Normal range (Male: 13.5–17.5 g/dL; Female: 12.0–15.5 g/dL)	Low hemoglobin levels (suggesting anemia, particularly acute during a hemolytic crisis)
Reticulocyte Count	Normal range (0.5% – 2.5% of total RBCs)	Elevated reticulocyte count (indicates bone marrow responding to rapid RBC destruction)
Serum Bilirubin (Total & Indirect)	Normal levels (Total: 0.2 – 1.2 mg/dL; Indirect: < 0.8 mg/dL)	Elevated indirect bilirubin (suggests active hemolysis and impaired clearance)
Haptoglobin Level	Normal range (30 – 200 mg/dL)	Significantly decreased or undetectable haptoglobin (indicates intravascular hemolysis)
Peripheral Blood Smear Examination	Normal RBC morphology (normocytic, normochromic erythrocytes)	Presence of Heinz bodies (precipitated hemoglobin) and bite cells (degmacytes)

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Ayzal Lab for G6PD?

• Experienced Healthcare Professionals: Our laboratory is staffed by highly qualified pathologists, technologists, and phlebotomists dedicated to diagnostic excellence.
• Patient-Focused Care: We prioritize patient comfort, safety, and clear communication throughout the testing process.
• Quality Diagnostic Services: Ayzal Lab adheres to strict internal and external quality control protocols to ensure reliable results.
• Professional Reporting: All test reports are thoroughly reviewed and verified by consultant pathologists before release.
• Modern Diagnostic Approach: We utilize advanced, automated laboratory equipment for precise enzyme assays and hematological profiles.
• Comfortable Environment: Our diagnostic centers in Lahore are designed to provide a clean, welcoming, and stress-free experience for patients of all ages.
• Convenient Location: Easily accessible facilities across Lahore make it simple for patients to visit for sample collection.
• Commitment to Accurate Diagnosis: We are dedicated to providing timely, clinically precise diagnostic insights to support your healthcare journey.